DermaProbe™
DSC_3580
DSC_3568
DSC_3587
DSC_3598

DermaProbe™


DermaProbe is a device for detecting malignant melanoma and other skin related diseases.

 

DermaProbe uses non-invasive dual-spectroscopy in combination with Corpus' proprietary analysis algorithms and AI technology.

 

DermaProbe is currently in use at Swedish hospitals. 

 

DermaProbe is developed by Corpus.



About our business


Summary of Business and Competence


Melanoma and DermaProbe


Neuropathy, clinical summary



Press release: Corpus announces DermaProbe™.


Press release: Linköping University Hospital purchases second DermaProbe.





To learn more about DermaProbe, feel free to contact us